
Thermo Fisher Scientific Inc.
TMO 578.71 (-0.24%) 1.42
Health Care
Life Sciences Tools and Services
Quality Checklist 5/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $217.43(B)
EV: $249.70(B)
Total Equity: $51.15(B)
Earnings date: Jan-29-2026
P/E: 33.37
Forward P/E: 25.46
P/FCF: 35.57
P/S: 5.01
P/B: 4.26
EPS: $17.3
EPS (fwd): $22.7
FCF/share: $16.3
Revenue/share: $115.4
Book value/share: $135.8
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.70
Current Ratio: 1.50
Gross margin: 41.4%
Operating margin: 18.4%
Net margin: 15.0%
Dividend/share: $1.7
Div. yield: 0.29%
TTM Financials
Income (TTM)
Revenue$43.74(B)
Gross profit$18.10(B)
EBITDA$10.84(B)
Net income$6.57(B)
Gross margin41.4%
Operating margin18.4%
Net margin15.0%
Shares outstanding375.71(M)
Balance sheet
Total assets$103.02(B)
Current assets$22.30(B)
Total liabilities$51.87(B)
Current liabilities$14.89(B)
Cash & Short-term inv.$3.55(B)
Long-term debt$31.66(B)
Total intangibles$65.53(B)
PP&E$10.18(B)
Cash flow (TTM)
FCF$6.11(B)
CapEx$-1.54(B)
Dividends paid$-623.00(M)
Stock issued$0
Stock repurchased$-3.96(B)
Stock-based comp.$305.00(M)
Debt issued$3.94(B)
Debt repaid$-4.72(B)
